NCT02135874
- Conditions
- Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Acute Biphenotypic Leukemia
Explore clinical trials studying Acute Biphenotypic Leukemia. Study availability and eligibility vary by location and protocol.
25 public trials
6 recruiting studies
Acute Biphenotypic Leukemia trial results
NCT01858740
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +41 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03096782
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01951885
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +41 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT03267186
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +23 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
NCT02728050
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00796068
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +25 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Oregon Health and Science University Portland, Oregon, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02529813
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +22 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of Colorado Denver, Colorado, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02044796
- Conditions
- Acute Biphenotypic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States